Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults

NCT01369862 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: GHB16L2
BIOLOGICAL: Placebo

Sponsor

AVIR Green Hills Biotechnology AG